Joseph J. Shatzel

Assistant Professor
Oregon Health & Science University

Presentation(s):

• LB 01.5 - Antiplatelet effects of inhibiting coagulation factor XI in a non-human primate model of atherosclerosis

  Sunday, July 10, 2022
  3:45 PM – 4:00 PM

• VPB0131 - Exogenous estrogen use for contraception and hormone replacement therapy and the risk of thrombosis in women with COVID-19

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• VPB0437 - Identifying Clinical Predictors for Thrombus Progression in Cirrhotic Patients with Untreated Splanchnic Vein Thrombosis

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM

• OC 58.4 - Ibrutinib inhibits BMX-dependent endothelial VCAM-1 expression in vitro and pro-atherosclerotic endothelial activation and platelet adhesion in vivo

  Tuesday, July 12, 2022
  11:30 AM – 11:45 AM

• OC 65.3 - A Phase 2 Trial Evaluating the Safety and Antithrombotic Efficacy of AB002, a First-in-class Protein C Activator in End-stage Renal Disease Patients on Heparin-free Hemodialysis

  Tuesday, July 12, 2022
  3:15 PM – 3:30 PM

• PB1144 - Outcomes with Perioperative Factor Utilization and Monitoring Strategies in Hemophilia A

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM